-
American Journal Of Gastroenterology Publishes Key Study Further Validating Esopredict® As A Prognostic Test For Barrett's Esophagus
12 Feb 2025 18:23 GMT
(MENAFN- PR Newswire)
BALTIMORE, Feb. 12, 2025 /PRNewswire/ -- Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of …
-
Researchers Develop Biomarker Algorithm for Noninvasive Detection of Barrett's Esophagus and Esophageal Cancer
23 Jan 2025 02:39 GMT
FOR IMMEDIATE RELEASE
By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a biomarker algorithm that, when …
-
Previse Showcases New Data Highlighting Clinical Utility of Esopredict® Barrett's Esophagus Prognostic Test at ACG 2024
28 Oct 2024 15:49 GMT
Epigenetic test for risk-stratification impacts gastroenterologists' decision making and improves confidence when caring for patients with Barrett's esophagus.
BALTIMORE, Oct. 28, 2024 /PRNewswire/ -- Previse, a gastrointestinal health …
-
First steps towards national screening for Barrett's esophagus
28 Oct 2024 02:12 GMT
Funder: Dr. Aoki is supported by theAPAGE/JGH Foundation Clinician-ScientistTraining Fellowship. Dr. Bulamu is supported bya Cancer Council South Australia Beat CancerEarly Career Research Fellowship
From: Flinders University
New research is exploring …
-
New Assay Predicts Cancer Risk in Barrett's Esophagus
30 Sep 2024 13:33 GMT
TOPLINE:
A new epigenetic assay is able to stratify patients with Barrett's esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 years, aiding in clinical decision-making.
…
-
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
06 Jun 2025 11:00 GMT
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory Board to …
-
Barrett's Esophagus: Patient-Centered Tx Approach Is Key
20 May 2024 07:51 GMT
The American Gastroenterological Association (AGA) has released updated evidence-based recommendations on the endoscopic eradication therapy (EET) of Barrett's esophagus (BE) and related neoplasms.
Published in Gastroenterology, the clinical practice …
-
WATS3D® Significantly Boosts Barrett's Esophagus and Dysplasia Detection Rates in Landmark Clinical Study
17 May 2024 00:00 GMT
Pivotal Multi-Center Study Highlights AI Platform's Powerful Diagnostic Impact and Ability to Enhance Patient Outcomes
SUFFERN, N.Y., May 17, 2024 /PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and …
-
Endoscopic Bile Reflux Strongly Associated with Barrett's Esophagus, finds study
03 May 2024 18:58 GMT
Researchers have found that endoscopic evidence of bile reflux is strongly associated with the presence of Barrett's esophagus. This finding comes from a retrospective analysis of a prospectively maintained database of consecutive patients who …
-
Woman With Dysphagia, Regurgitation, and Throat Burning
03 Jun 2025 19:56 GMT
Editor's Note:
The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians, but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills using …